Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Immunology of Neuromyelitis Optica—Current Knowledge, Clinical Implications, Controversies and Future Perspectives
Michalina Jasiak-Zatońska, Alicja Kalinowska-Łyszczarz, S. Michalak, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 3, pp. 273-273
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis
Bruna Garbugio Dutra, Antônio José da Rocha, Renato Hoffmann Nunes, et al.
Radiographics (2018) Vol. 38, Iss. 1, pp. 169-193
Closed Access | Times Cited: 146
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
Wojciech Ambrosius, S. Michalak, Wojciech Kozubski, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 100-100
Open Access | Times Cited: 122
Diagnosis and management of neuromyelitis optica spectrum disorders - An update
Alice Bruscolini, Marta Sacchetti, Maurizio La Cava, et al.
Autoimmunity Reviews (2018) Vol. 17, Iss. 3, pp. 195-200
Closed Access | Times Cited: 110
Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies
Chen Ding, Sandra Gallagher, Nancy Monson, et al.
Journal of Clinical Medicine (2016) Vol. 5, Iss. 12, pp. 107-107
Open Access | Times Cited: 94
Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
Tianjiao Duan, Alexander J. Smith, A. S. Verkman
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 72
Epidemiology of NMOSD in Sweden from 1987 to 2013
Dagur Ingi Jonsson, Ólafur Sveinsson, Ramil Hakim, et al.
Neurology (2019) Vol. 93, Iss. 2
Open Access | Times Cited: 60
Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders
Maureen A. Mealy, Su‐Hyun Kim, Felix Schmidt, et al.
Multiple Sclerosis Journal (2017) Vol. 24, Iss. 13, pp. 1737-1742
Open Access | Times Cited: 51
Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
James E. Frampton
Drugs (2020) Vol. 80, Iss. 7, pp. 719-727
Open Access | Times Cited: 48
Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD
Vyanka Redenbaugh, Eoin P. Flanagan
Neurotherapeutics (2022) Vol. 19, Iss. 3, pp. 808-822
Open Access | Times Cited: 26
Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases
Wessam E. Sharaf‐Eldin, Nirmeen A. Kishk, Yehia Z. Gad, et al.
Journal of the Neurological Sciences (2017) Vol. 383, pp. 188-198
Closed Access | Times Cited: 45
Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects
Staley A. Brod
Multiple Sclerosis and Related Disorders (2020) Vol. 46, pp. 102538-102538
Open Access | Times Cited: 37
Clostridium bolteae is elevated in neuromyelitis optica spectrum disorder in India and shares sequence similarity with AQP4
Lekha Pandit, Laura M. Cox, Chaithra Malli, et al.
Neurology Neuroimmunology & Neuroinflammation (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 36
Inebilizumab for treatment of neuromyelitis optica spectrum disorder in patients with prior rituximab use from the N-MOmentum Study
Eoin P. Flanagan, Michael Levy, Eliezer Katz, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 57, pp. 103352-103352
Open Access | Times Cited: 32
Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review
Xiaoqian Song, Jingjiao Chen, C. J. Jin, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Serum Lipid Biomarkers for the Diagnosis and Monitoring of Neuromyelitis Optica Spectrum Disorder: Towards Improved Clinical Management
Ruibing Li, Jinyang Wang, Jianan Wang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3779-3794
Open Access
Decoding Autoimmunity: Insights Into Neuromyelitis Optica and Its Relationship With Other Autoimmune Neurological Disorders
Tabish W Siddiqui, Raqshan W Siddiqui, Shiza W Siddiqui, et al.
Cureus (2025)
Open Access
Atypical Presentation or Variants of Multiple Sclerosis
Eleni Litsou
IntechOpen eBooks (2025)
Closed Access
Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials
Sonia Labrador-Velandia, María Luz Alonso-Alonso, Sara Alvarez-Sanchez, et al.
World Journal of Stem Cells (2016) Vol. 8, Iss. 11, pp. 376-376
Open Access | Times Cited: 34
Optical Coherence Tomography Angiography of Peripapillary Vessel Density in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Comparative Study
Małgorzata Rogaczewska, S. Michalak, Marcin Stopa
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 609-609
Open Access | Times Cited: 25
Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using optical coherence tomography angiography
Małgorzata Rogaczewska, S. Michalak, Marcin Stopa
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Downregulation of lncRNA XIST may promote Th17 differentiation through KDM6A-TSAd pathway in neuromyelitis optica spectrum disorders
Ruoyi Guo, Shuang Song, Jue-Qiong Wang, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 76, pp. 104801-104801
Closed Access | Times Cited: 10
Exploration of the causal associations between circulating inflammatory proteins, immune cells, and neuromyelitis optica spectrum disorder: a bidirectional Mendelian randomization study and mediation analysis
Zhiqing Chen, Yujin Guo, Huaiyu Sun, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 3
Th17-Related Cytokines as Potential Discriminatory Markers between Neuromyelitis Optica (Devic’s Disease) and Multiple Sclerosis—A Review
Karina Maciak, Sylwia Pietrasik, Angela Dziedzic, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8946-8946
Open Access | Times Cited: 23
Clinical characteristics of 153 Brazilian patients with neuromyelitis optica spectrum disorder (NMOSD)
Yára Dadalti Fragoso, Nise Alessandra C. Sousa, Soniza Vieira Alves‐Leon, et al.
Multiple Sclerosis and Related Disorders (2018) Vol. 27, pp. 392-396
Closed Access | Times Cited: 26
The expansion of circulating IL-6 and IL-17-secreting follicular helper T cells is associated with neurological disabilities in neuromyelitis optica spectrum disorders
Clarice Monteiro, Gabriel Fernandes, Taissa M. Kasahara, et al.
Journal of Neuroimmunology (2019) Vol. 330, pp. 12-18
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top